Consensus guidelines for the management of patients with digestive neuroendocrine tumors - Well-differentiated jejunal-ileal tumor/carcinoma

Authors :: Eriksson, B.
Klöppel, G.
Krenning, E.
Ahlman, H.
Plöckinger, U.
Wiedenmann, B.
Arnold, R.
Auernhammer, C.
Körner, M.
Rindi, G.
Wildi, S.
Caplin, M.
Fave, G. D.
Ferone, D.
Goretzki, P.
Hyrdel, R.
Jensen, R.
Kaltsas, G.
Keleştimur, F.
Kianmanesh, R.
Komminoth, P.
Kos Kudła, B.
Kvols, L.
Kwekkeboom, D.
Lopes, J.
Manfredi, Riccardo
Mcnicol, A.
Niederle, B.
Nilsson, O.
Nikou, G.
Öberg, K.
O'Connor, J.
O'Toole, D.
Pavel, M.
Perren, A.
Ramage, J.
Ricke, J.
Ruszniewski, P.
Scarpa, Aldo
Scoazec, J.
Garcia, M. S.
Steinmüller, T.
Taal, B.
Vullierme, M.
Yao, J.
Radiology & Nuclear Medicine
Source :: Neuroendocrinology, 87(1), 8-19. Karger
Publication Year :: 2008
Abstract: Consensus guidelines for the management of patients with digestive neuroendocrine tumors : well-differentiated jejunal-ileal tumor/carcinoma

Subjects :: medicine.medical_specialty
Pathology
Consensus
MIDGUT CARCINOID-TUMORS, ENDOCRINE GASTROENTEROPANCREATIC TUMORS, RECEPTOR-MEDIATED RADIOTHERAPY, RADIOLABELED SOMATOSTATIN ANALOG, RECOMBINANT INTERFERON-ALPHA, RADIONUCLIDE THERAPY
MIDGUT CARCINOID-TUMORS
Endocrinology, Diabetes and Metabolism
RADIONUCLIDE THERAPY
Neuroendocrine tumors
digestive system
RECOMBINANT INTERFERON-ALPHA
Cellular and Molecular Neuroscience
Endocrinology
Internal medicine
Carcinoma
Humans
Medicine
ENDOCRINE GASTROENTEROPANCREATIC TUMORS
Gastrointestinal Neuroendocrine Tumor
RADIOLABELED SOMATOSTATIN ANALOG
Jejunal Neoplasms
Endocrine and Autonomic Systems
business.industry
digestive, oral, and skin physiology
Metastatic carcinoid tumor
Cancer
medicine.disease
Carcinoma, Neuroendocrine
Well differentiated
Ileal Neoplasms
Practice Guidelines as Topic
Radionuclide therapy
Neuroendocrine therapy
business
RECEPTOR-MEDIATED RADIOTHERAPY

Full Text Access

Tools